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ABSTRACT
We develop a multiphysics-based model to predict the response of localized tumors to
combined-hyperthermia-radiotherapy (CHR) treatment. This procedure combines hyper-
thermia (tumor heating) with standard radiotherapy to improve efficacy of the overall
treatment. In addition to directly killing tumor cells, tumor heating amends several pa-
rameters within the tumor microenvironment. This leads to radiosensitization, which im-
proves the performance of radiotherapy while reducing the side-effects of excess radiation
in the surrounding normal tissue. Existing tools to model this kind of treatment consider
each of the physics separately. The model presented in this paper accounts for the synergy
between hyperthermia and radiotherapy providing a more realistic and holistic approach
to simulate CHR treatment. Our model couples radiation transport and heat-transfer with
cell population dynamics.
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1. INTRODUCTION
Radiotherapy is one of the most widely used modalities for palliative and therapeutic cancer care
[1]. Its performance depends on energy deposition, and the resulting effects on tumor and sur-
rounding healthy tissue. While the dose profile is controlled through the choice of radiation and
delivery method [2], its effects on tissue can be manipulated using chemical radiosensitizers [3]
and/or tumor heating [4]. The use of radiosensitizers enhances cell kill and allows for optimization
of radiation dosage and scheduling such that the collateral damage to the normal tissue can be
minimized. Cytotoxic effects of heat shocks and their role in radiosensitization for radiotherapy
have been of interest since the 1970s.
There are mechanistic differences in how heat and radiation damage cells [5]. This allows for ad-
ditive use of hyperthermia and radiotherapy. The role of hyperthermia in radiochemosensitization,
without the introduction of systemic toxicity, is also well known [6]. This allows for the synergis-
tic use of hyperthermia and radiotherapy. Therefore, hyperthermia can be used with radiotherapy
both additively and synergistically. Several randomized trials have demonstrated clinical benefits
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of using hyperthermia in combination with radiotherapy [5]. Hyperthermia is a fully approved part
of cancer care in European countries like Germany and the Netherlands.
Radiation dosimetry has traditionally been treated as single physics [7]. However, the modeling
of tumor response to radiotherapy could benefit from the coupling of dose deposition with other
relevant physics. When patients are exposed to heat and radiation, tumors undergo constitutive
changes. Taking these changes into account simultaneously with the radiation dose deposition,
should provide a more realistic and effective approach to model treatment. For example, hyper-
thermia increases radiosensitivity in certain types of tumor cells, making tumors more susceptible
to radiation treatment [4]. Therapies such as Combined-Hyperthermia-Radiotherapy (CHR) make
use of this effect.
To appropriately model the overall effect, the synergy between features such as tumor heating,
radiation dosimetry, and tumor dynamics should be considered simultaneously. Furthermore, there
are cases in which the target organs are in constant motion (e.g. lungs), thereby constantly shift-
ing the location of the tumor (in center-of-mass frame). This motion should be accounted for in
real time while treating tumors using external radiation beams and mathematically modeling their
response. Coupled/multiphysics modeling could prove to be a powerful tool to determine tumor
dynamics in such systems. Other treatment modalities include a combination of radiotherapy with
immunotherapy [8], and radiotherapy with chemotherapy [9]. For such combined treatments, the
accurate determination of tumor response should also be performed using multiphysics models.
Several studies have presented work on mathematical tumor dynamics modeling. Ordinary and
partial differential equations are used to model these systems in [10] and [11]. Radiotherapy-
specific tumor dynamics models have been introduced in [12] and [13]. Moreover, internal radia-
tion dosimetry has been extensively treated using the Monte Carlo method [14]. In this work, we
introduce the idea of a novel multiphysics-based approach to mathematically model CHR systems.
This model couples radiation transport (and dosimetry), heat transfer, and cell population dynam-
ics. To our knowledge, this is the first attempt to develop a multiphysics model for tumor response
to CHR.
This is by no means an exhaustive study. The test problems in this preliminary work do not
model real-world treatment scenarios; the governing equations and treatment specifics are heavily
simplified. These are not the subject of investigation in this report; our goal is to provide a first
step towards building a fully-coupled multiphysics model for this type of treatment, with the focus
of this paper being the introduction to the coupled approach.
The remainder of this paper is organized as follows. In Section 2, we introduce relevant physics,
governing equations, coupling, and numerical approach. In Section 3, we furnish our example
problems and provide numerical results. We conclude this paper with a brief discussion in Sec-
tion 4.
2. GOVERNING EQUATIONS
The model to describe tumor dynamics during CHR treatment incorporates three physics: 1) ra-
diation transport to model internal dosimetry, 2) heat transfer to incorporate the effects of tumor
heating, and 3) cell population dynamics to determine how the tumor responds to the combination
of hyperthermia with radiotherapy. Our preliminary model is one-dimensional in space, monoen-
ergetic, and assumes isotropic scattering.
2.1. Radiation Transport and Dosimetry
The following monoenergetic Boltzmann transport equation with isotropic scattering is used to
model the flux distribution [15]:
1
v
∂ψ
∂t
+ µ
∂ψ
∂x
+ σt(x)ψ =
σs(x)
2
φ(x, t) +
Q(x, t)
2
, (1)
where ψ = ψ(x, µ, t) represents the angular flux at position x and along direction µ at time t; v
is the photon speed; φ is the scalar flux; σt is the total macroscopic cross-section; σs is the 0th
moment of the scattering cross-section; and Q is an internal source. The dose is calculated using
the following equation [16]:
D(x, t) =
(
µen
ρ
)
Φ(x, t)E, (2a)
Φ(x, t) =
∫ t
0
dt′φ(x, t′). (2b)
Here, D represents the dose; µen
ρ
is the mass energy absorption coefficient; E is the energy per
photon; and Φ is the fluence at time t. We calculate the effective dose DE using the standard
linear-quadratic model [5]:
DE(x, t) = αD(x, t) + βD
2(x, t), (3)
where α and β are radiobiology parameters that determine relative contribution of each term in the
sum toward the total radiation effect [5]. The cell survival probability S is chosen in such a way
that a larger dose results in smaller survival probability, as given by [12]:
S(x, t) = e−DE(x,t). (4)
2.2. Hyperthermia and Heat Transfer
Thermal medicine is slowly increasing its presence in cancer care. Several techniques, such as
radiofrequency and ultrasound ablation, have been developed to provide focused heating inside
tumors [5]. While the use of a more sophisticated heat transport model is warranted, we use simple
heat conduction to model hyperthermia [17]:
ρcp
∂T (x, t)
∂t
=
∂
∂x
κ
∂T (x, t)
∂x
+ q(x), (5)
where cp, ρ, and κ are the specific heat capacity, the material density, and the thermal conductivity
of tissue respectively (assumed constant). Moreover, q is the volumetric heat source.
2.3. Cell Population Dynamics
We assume that tumor growth depends on three factors: proliferation, invasion, and cell kill in-
duced by treatment. Proliferation determines the balance between cell division and cell loss due
to natural death; cell proliferation is higher in tumors. Invasion essentially determines the trans-
port of tumor cells in the area of interest; continuum-based approaches to model tumor dynamics
often use Fick’s law to describe invasion. Two proliferation models are widely considered in the
literature: exponential and logistic. Though less suitable for problems considering realistic tumor
growth time-frames (months to years), we use the exponential model because our test problems
consider tumor dynamics over a short period of thirty minutes. The following balance equation
determines tumor cell concentration, c(x, t), over time [12]:
∂c
∂t
=
∂
∂x
(
I
∂c
∂x
)
+ pc(x, t) −R(x, t)c(x, t). (6)
The equation above equates the rate of change of tumor cell concentration with the sum of net
dispersal rate, net proliferation rate, and loss of tumor cells due to therapy. Here, I is the diffusion
coefficient representing motility of tumor cells; p is the proliferation rate; and R represents the
effect of therapy on cell kill [12,18]. Under stand-alone radiotherapy,
R = 1 − S. (7)
Patient-specific invasion and proliferation rates can be obtained using MRI images [12]. We define
how supplemental heat affects radiotherapy next.
2.3.1. Radiosensitivity parameter
As mentioned in Section 1, heat affects the radiosensitivity of tissue. Traditionally, this is ex-
pressed using the thermal enhancement ratio (TER) [5], which defines the ratio of dose required
to produce a given level of biological damage with and without heat. Experiments have measured
TER for various types of tumors [19]. Some experiments have seen TER values as high as 4.3
under favorable environments [5]. In this paper, we express this in a different way: we introduce
a radiosensitivity parameter, ξ, to collectively account for the additive and synergistic effects of
hyperthermia. We define this parameter as the ratio of the biological damage caused by a given
amount of radiation dose to tissue with and without heating. Setting the relevant biological effect
to be R,
ξ(Tavg, t) =
RCHR
RRT
, (8)
where RCHR quantifies the combined effect of heat and radiation on irradiated tissue, and RRT
represents the effect of stand-alone radiotherapy. Tavg is the time-averaged value of temperature at
time t. Combining Eqs. (7) and (8), we obtain
RCHR = ξRRT = ξ(1 − S). (9)
At normal body temperature, ξ = 1 irrespective of time; we also set ξ at time zero to be unity.
We arbitrarily assume ξ = 2.5 for our system when the tumor is heated to an average temperature
of 45◦C over 30 minutes. In order to define ξ elsewhere, we employ bilinear interpolation [20]
between the data points ξ(37, 0) = 1, ξ(37, 30) = 1, ξ(45, 0) = 1 and ξ(45, 30) = 2.5. This
returns:
ξ(Tavg, t) = 1 − 0.23125Tavg + 0.00625(Tavg × t). (10)
Several simplifying assumptions have been made in this model. We do not consider temperature
dependent cross-sections for transport. Material density change with heating is ignored. Moreover,
we assume that the decay heat is negligible compared to the constant volumetric heat source in
the heat equation. These simplifications allow us to get a one-way coupled system. We plan
to eliminate these assumptions and model this system with a fully-coupled framework in a later
paper.
3. ONE-WAY COUPLED CHRMODELING
The interaction of Eqs. (1), (2a), (3) to (7), (9) and (10) determines the tumor response over time.
While our problem is set in slab geometry and is one-way coupled, real-world problems are in
general more complex. Transport alone can depend on seven independent variables [15], making its
full coupling with other physics difficult. Moment-based nonlinear acceleration schemes, such as
nonlinear diffusion acceleration (NDA), aid in accelerating the convergence of slowly converging
physics and allow us to isolate the angular flux from the coupled set of physics by introducing a
discretely consistent low-order (LO) equation [21]. The system of equations for nonlinear diffusion
acceleration is the following:
1
v
∂ψHO
∂t
+ µ
∂ψHO
∂x
+ σtψ
HO =
σs(x)
2
φLO +
Q
2
, (11a)
1
v
∂φLO
∂t
+
∂
∂x
(
−D∂φLO
∂x
+ DˆφLO
)
+ σaφ
LO = Q, (11b)
Dˆ =
JHO +D ∂φ
HO
∂x
φHO
, (11c)
JHO =
∫ 1
−1
µψdµ . (11d)
Here, J is the current, D = 1
3σt
is the diffusion coefficient, and Dˆ is the consistency parameter.
The high-order (HO) transport equation (11a) couples with the diffusion-like LO equation (11b) via
the closure relations described in Eqs. (11c) and (11d), forming the high-order low-order (HOLO)
system of equations. Nonlinear diffusion acceleration is achieved by simultaneous solution of
Eqs. (11a) to (11d). We discretize the HO equation using the standard backward Euler method in
time and diamond-difference/discrete ordinates scheme in space/angle. The heat, cell population
dynamics, and the LO equations employ backward Euler and central finite difference for time/space
discretization.
Although the schemes used in this paper are well-known, we briefly present them for completeness.
The discretized transport equation is written as:
1
v
ψi,n,k − ψi,n,k−1
∆t
+ µn
ψi
1+12
,n,k − ψi
1− 12
,n,k
∆x
+ σt,iψi,n,k =
σs,i
2
φi,k +
Qi,k
2
(12a)
ψi,n,k =
ψi
1+12
,n,k + ψi
1− 12
,n,k
2
. (12b)
Here, i, n, and k represent spatial, angular, and temporal indices respectively. Integer index values
represent cell-centers and fraction values represent cell-edges. Equations (2a), (3) and (4) can be
easily discretized in the same fashion. The LO equation uses the following discretization [22]:
1
v
φi,k − φi,k−1
∆t
−Dφi+1,k − 2φi,k + φi+1,k
∆x2
+
Dˆi+ 1
2
2∆x
(φi+1,k + φi,k) (13)
−
Dˆi− 1
2
2∆x
(φi,k + φi−1,k) + σaφi,k = Qi,k.
The standard centered-space-backward-time discretization for the heat equation is given by
ρcp
Ti,k − Ti,k−1
∆t
= κ
Ti+1,k − 2Ti,k + Ti−1,k
∆x2
+ qi, (14)
while the cell population dynamics equation is written as
ci,k − ci,k−1
∆t
= I
ci+1,k − 2Ci,k + ci−1,k
∆x2
+ pci,k −Ri,kci,k. (15)
The coupling and solution can be represented via the following Newton step:
JφLOφLO 0 0 0 0 0
JφLOΦ JΦΦ 0 0 0 0
0 JΦDE JDEDE 0 0 0
0 0 0 JTT 0 0
0 0 JDER JTR JRR 0
0 0 0 0 JRc Jcc


δφLO
δΦ
δDE
δT
δR
δc
 = −

FφLO
FΦ
FDE
FT
FR
Fc
 , (16)
where FφLO ,FΦ, FDE , FT , FR, and Fc are the residual forms of the relevant equations for flux,
fluence, effective dose, temperature, effect of therapy on cell kill, and tumor cell concentration.
Since the Jacobian matrix above is not block-diagonal, the physics are interrelated and therefore
warrant a multiphysics treatment. The one-way coupling (represented by the lower-triangular Ja-
cobian matrix) allows us to solve the problem in a serial fashion, in which we solve transport first
to determine flux, fluence, dose, effective dose, and the survival probability (in that order). Next,
we solve the heat equation to determine the temperature, followed by heat-adjusted effect of ra-
diation on tissue. Finally, we calculate the tumor cell concentration using parameters obtained by
solving the previous equations and move on to the next time step. This kind of modeling allows
us to continuously track tumor cell density over time. For each of the test problems, we choose a
uniform time step of ∆t = 0.025 s and 270 spatial cells. The solutions obtained are converged to at
least four digits precision for this discretization. We set the angular discretization for the transport
equation to eight angles. The convergence tolerance for transport solves is set to 10−6. The heat
and tumor dynamics equations are solved using MATLAB’s backslash function [23].
3.1. Test Problem
We consider the evolution of tumor-cell concentration distribution in a three-region slab over a
period of thirty minutes. The first and the third regions, each 14 mm thick, represent healthy soft-
tissue. The second soft-tissue region (in the middle) is 2 mm thick, and has uniformly distributed
tumor cells with a concentration of 220 cells
cm3
. This region maintains an exponentially decaying
internal radiation source with a half life of 75 days. The average photon energy of the source is
0.4 MeV. In order to induce hyperthermia, this region also has a constant volumetric heat source.
Specific values of the radiation and the heat source will be provided in the next subsection. We use
vacuum boundaries for transport, and open boundaries for the heat and tumor dynamics equations.
We assume the parameters presented in Table 1 [12,24,25]. We follow existing literature and
assume similar continuum properties for both healthy and tumor tissue. We represent the transport
in healthy and tumor tissues using the same parameters. The total cross-section (total attenuation
coefficient) is 0.1053578 cm−1; and the scattering cross-section is 0.105324 cm−1 [25].
Table 1: Parameters
I p α α
β
κ cp ρ
µen
ρ
[mm/yr] [/yr] [kg/J] [J/kg] [W/m.K] [kJ/kg.K] [g/cc] [cm2/g]
4.29 35.13 0.203 10 0.51 3.68 1.0 0.0325
3.2. Numerical Results
First, we demonstrate that the use of a scale-bridging HOLO algorithm returns the same tumor
response profile to CHR treatment as stand-alone source iteration [15]. We also analyze how
increasing radiation source strength affects the tumor response. Specifically, we consider three
initial source strengths for the tumor region: Q0 = 1.4 × 105, 2.8 × 105, and 5.6 × 105 photonscm3s .
Everything else is the same as previously described.
(a) HOLO vs. Source Iteration (b) Tumor response to different sources
Figure 1: Tumor response to stand-alone radiotherapy
We observe in Fig. 1 that both methods return tumor cell concentration within the prescribed tol-
erance. This means it is valid to introduce HOLO acceleration into the multiphysics algorithm.
Moreover, according to Fig. 1b, increasing source strength improves the overall cell kill as ex-
pected. We note that this study is not prescriptive.
Next, we consider tumor dynamics in three scenarios: 1) untreated tissue (no radiation or heat
source), 2) slab with an initial isotropic internal radiation source of 5.6 × 105 photons
cm3s
in the tumor
region, and 3) slab with an initial isotropic internal radiation source of 5.6× 105 photons
cm3s
and a heat
source of 1
3
W
cm3
in the tumor region.
Figure 2 shows that the introduction of radiation in the tumor begins to kill cancer cells and reduces
the total tumor cell concentration in the slab after thirty minutes of treatment. Introduction of heat
enhances the cell kill; this is evident from the further reduction in tumor cell concentration.
Finally, we compare tumor response to CHR treatment with different heat sources. We vary the
Figure 2: Tumor cell concentration comparison
strength of the volumetric heat source in the tumor region of the model slab: q = 1
27
, 1
9
, and 1
3
W
cm3
,
and we fix Q0 at 5.6 × 105 photonscm3s . We find from Fig. 3 that increasing the strength of the heat
source indeed results in a higher tumor cell kill. This is attributed to increased radiosensitivity in
tumor tissue due to the introduction of hyperthermia.
Figure 3: Tumor response to different heat sources
4. CONCLUSIONS
We presented a one-way coupled multiphysics model to determine tumor response to CHR treat-
ment. We observed that the introduction of radiation results in tumor cell kill. Moreover, introduc-
tion of heat enhances radiosensitivity of the tumor cells, which increases the cell kill. We made
several simplifying assumptions and chose a simple geometry to demonstrate the concept behind
this multiphysics model. We plan to eliminate these simplifying assumptions in subsequent pa-
pers such that real-world treatments can be modeled. Specifically, we will introduce anisotropic
scattering, higher dimensions, and energy dependence into our transport model. This will call for
an efficient nonlinear HOLO scheme for forward-peaked transport problems; we will endeavour
to develop such a method. We also plan to extend this model to address random tumor media.
Moreover, we understand the importance of developing a benchmark to verify future models and
code implementations. This will constitute a major portion of our future work in CHR modeling.
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